ETON vs. GREK
ETON (Eton Pharmaceuticals Inc) is a stock, while GREK (Global X MSCI Greece ETF) is Emerging Markets Equities fund tracking the MSCI All Greece Select 25-50. Over the past 5 years, ETON returned 36.00%/yr vs 24.30%/yr for GREK. At a 0.15 correlation, their price movements are largely independent.
Performance
ETON vs. GREK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ETON achieves a 86.81% return, which is significantly higher than GREK's 15.45% return.
ETON
- 1D
- -1.62%
- 1M
- 2.50%
- YTD
- 86.81%
- 6M
- 89.16%
- 1Y
- 117.71%
- 3Y*
- 102.22%
- 5Y*
- 36.00%
- 10Y*
- —
GREK
- 1D
- 0.87%
- 1M
- 5.63%
- YTD
- 15.45%
- 6M
- 15.54%
- 1Y
- 38.63%
- 3Y*
- 32.67%
- 5Y*
- 24.30%
- 10Y*
- 16.01%
ETON vs. GREK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
ETON Eton Pharmaceuticals Inc | 86.81% | 26.95% | 204.11% | 55.32% | -34.27% | -47.23% | 12.92% | 17.65% | -4.23% |
GREK Global X MSCI Greece ETF | 15.45% | 76.11% | 9.53% | 42.72% | 3.64% | 6.14% | -13.89% | 50.20% | -5.64% |
Correlation
The correlation between ETON and GREK is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Nov 13, 2018 | 0.15 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ETON vs. GREK — Risk / Return Rank
ETON
GREK
ETON vs. GREK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Eton Pharmaceuticals Inc (ETON) and Global X MSCI Greece ETF (GREK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ETON | GREK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.57 | ||
| Sortino ratioReturn per unit of downside risk | +0.46 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.28 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | 3.27 | 1.82 | +1.45 |
| Martin ratioReturn relative to average drawdown | 6.73 | 5.62 | +1.11 |
Loading charts...
Drawdowns
ETON vs. GREK - Drawdown Comparison
The maximum ETON drawdown since its inception was -79.94%, roughly equal to the maximum GREK drawdown of -79.50%. Use the drawdown chart below to compare losses from any high point for ETON and GREK.
Loading charts...
Drawdown Indicators
| ETON | GREK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -79.94% | -79.50% | -0.44% |
Max Drawdown (1Y)Largest decline over 1 year | -36.17% | -21.32% | -14.85% |
Max Drawdown (3Y)Largest decline over 3 years | -45.65% | -22.63% | -23.02% |
Max Drawdown (5Y)Largest decline over 5 years | -70.42% | -30.46% | -39.96% |
Max Drawdown (10Y)Largest decline over 10 years | — | -57.04% | — |
Current DrawdownCurrent decline from peak | -9.74% | -1.44% | -8.30% |
Average DrawdownAverage peak-to-trough decline | -37.58% | -45.25% | +7.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.56% | 6.90% | +10.66% |
Volatility
ETON vs. GREK - Volatility Comparison
Eton Pharmaceuticals Inc (ETON) has a higher volatility of 17.63% compared to Global X MSCI Greece ETF (GREK) at 8.69%. This indicates that ETON's price experiences larger fluctuations and is considered to be riskier than GREK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ETON | GREK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.63% | 8.69% | +8.94% |
Volatility (6M)Calculated over the trailing 6-month period | 40.49% | 20.65% | +19.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.85% | 24.35% | +30.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 63.41% | 24.44% | +38.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 63.87% | 29.71% | +34.16% |
Dividends
ETON vs. GREK - Dividend Comparison
ETON has not paid dividends to shareholders, while GREK's dividend yield for the trailing twelve months is around 3.00%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ETON Eton Pharmaceuticals Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GREK Global X MSCI Greece ETF | 3.00% | 3.46% | 4.63% | 2.61% | 2.82% | 2.16% | 2.62% | 2.25% | 2.41% | 2.13% | 1.95% | 1.52% |
Frequently Asked Questions
ETON and GREK have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ETON has higher volatility (17.63%) compared to GREK (8.69%). In terms of maximum drawdown, ETON dropped -79.94% vs GREK's -79.50%.
ETON currently has the higher Sharpe Ratio (2.16 vs 1.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ETON and GREK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer